We Support Your Complete Drug Development Process

Accelerate Your Development Program with Pinpoint Therapeutic Focus and Complete Spectrum of Services 

Worldwide Clinical Trials is a global CRO that provides full-service drug development services to the pharmaceutical and biotechnology industries.   As one of the most innovative and scientifically-driven contract research organizations, we offer exceptionally strong clinical trial methodology integrated with an effective global operations network. 

Our Therapeutic Focus is Highly Targeted 

Worldwide Clinical Trials Inc. is known for its innovative and methodologically rigorous clinical research in the following key therapeutic areas:

Our Spectrum of Services 

While Worldwide Clinical Trials supports you in your pre-registration through peri-approval studies, our sister division, Worldwide Clinical Trials Early Phase Services and Bioanalytical Sciences, specializes in bioanalytical and early phase development.  This powerful combination of services insures that you are working with a CRO that can understand and meet the needs of your entire drug development program.  We believe this is important because the best partners in your business have a long term commitment and passion for bringing your drug to the market.

Early Phase Services and Bioanalytical Sciences  

Worldwide Clinical Trials Early Phase Services and Bioanalytical Sciences offers bioanalytical and clinical research services, as well as specialized studies to determine the effects of dose, formulation, dosing regimen, drug interactions, genotype, gender and other factors on pharmacokinetics. We provide expert advice on everything from protocol development to regulatory submission.

Clinical Development   

Worldwide Clinical Trials approaches every Phase I-IV  drug development program as unique and  thus are known for our highly consultative approach  in developing solutions based on your specific development and commercialization needs.   

Our  unique and analytical five step approach, Methods in Medicine, ensures that your development program  is successful. 

 

Methods in Medicine

 

Development to Commercialization  

Worldwide Clinical Trials recognizes that drug approval is only half the battle.   Without payer and reimbursement support of your drug , your investment has been futile.  We believe commercialization considerations are no longer only a Phase IV focus but rather now must be integrated in early in the clinical and strategic development of your drug development program.

For this reason, we work in partnership with some of the most highly respected HEOR and health policy experts in the world.  Our symbiotic relationship with our partners ensures that:

  • You prioritize your development portfolio based on those drugs most likely to succeed in the marketplace
  • Phase II and Phase III drug development programs are designed to provide payers and reimbursement authorities answers they need to establish access at your drugs approval – not after.
  • We help you design Phase IV programs that are based on regulatory requirements, commercial insights and payer needs, all optimizing your ability to accelerate market penetration and share.